180 Wealth Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

180 Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$282K	Hold	8,321	–	–	0.03%	395
2026 Q1	$251K	Hold	8,321	–	–	0.03%	400
2025 Q4	$260K	Buy	+8,321	New	+$205K	0.03%	393
2021 Q4	–	Sell	-10,439	Closed	-$101K	–	407
2021 Q3	$101K	Hold	10,439	–	–	0.02%	373
2021 Q2	$105K	Buy	+10,439	New	+$110K	0.02%	356

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

180 Wealth Advisors's TEVA Position: Q2 2026 in Review

180 Wealth Advisors held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2026 at 8,321 shares worth $282K. The position accounts for 0.03% of the portfolio, ranked #395.

180 Wealth Advisors first reported a position in TEVA in Q2 2021 and has held it in 5 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

180 Wealth Advisors held 8,321 shares of Teva Pharmaceutical Industries Limited worth $282K as of Q2 2026.
180 Wealth Advisors left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2026.
Teva Pharmaceutical Industries Limited made up 0.03% of 180 Wealth Advisors's portfolio in Q2 2026, its #395 holding.
180 Wealth Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2021 and has held it in 5 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.